2012
DOI: 10.1016/j.peptides.2012.09.031
|View full text |Cite
|
Sign up to set email alerts
|

The permeation of dynorphin A 1–6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeability

Abstract: Dynorphin A 1–17 (Dyn A 1–17) is an endogenous neuropeptide known to act at the kappa opioid receptor; it has been implicated in a number of neurological disorders, including neuropathic pain, stress, depression, and Alzheimer’s and Parkinson’s diseases. The investigation of Dyn A 1–17 metabolism at the blood-brain barrier (BBB) is important since the metabolites exhibit unique biological functions compared to the parent compound. In this work, Dyn A 1–6 is identified as a metabolite of Dyn A 1–17 in the prese… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Dynorphin A (Dyn A) is an endogenous opioid peptide that is derived from the precursor peptide preprodynorphin . This peptide has high affinity for the κ‐opioid receptor . Dyn A has been found to exhibit both antinociceptive and analgesic effects within the central nervous system and is also involved in the body's immune response as well as cardiovascular and temperature regulation .…”
Section: Introductionmentioning
confidence: 99%
“…Dynorphin A (Dyn A) is an endogenous opioid peptide that is derived from the precursor peptide preprodynorphin . This peptide has high affinity for the κ‐opioid receptor . Dyn A has been found to exhibit both antinociceptive and analgesic effects within the central nervous system and is also involved in the body's immune response as well as cardiovascular and temperature regulation .…”
Section: Introductionmentioning
confidence: 99%